Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.03)
# 569
Out of 4,981 analysts
596
Total ratings
47.66%
Success rate
12.99%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $405.02 | +23.45% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $144.86 | +33.92% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $7.02 | +70.94% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $14.01 | +92.72% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $4.79 | +380.17% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $47.00 | +27.66% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $23.61 | +35.54% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $394.53 | +39.41% | 27 | Jun 23, 2025 | |
| INSM Insmed | Maintains: Buy | $90 → $120 | $145.93 | -17.77% | 15 | Jun 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $14 → $8 | $1.48 | +440.54% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $3.55 | -43.66% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $25.99 | +34.67% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $8.21 | +70.52% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $23.46 | +49.19% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $2.42 | +478.51% | 15 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $20.91 | +258.68% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $44.74 | +51.99% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $2.75 | +263.64% | 10 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $13.14 | +189.30% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $11.65 | +37.34% | 20 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $15.74 | +58.83% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $14.19 | +125.51% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.91 | +279.27% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $9.87 | +62.11% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $7.74 | +210.08% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.43 | +393.83% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $56.84 | -33.15% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.60 | +207.69% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $141.90 | +18.39% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $4.09 | +71.15% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.32 | +733.33% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.49 | +571.14% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $6.97 | +215.64% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.88 | +128.08% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.21 | +444.22% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.19 | +150.48% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.02 | +56.70% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.14 | +632.48% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.76 | +752.27% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $69.53 | +22.25% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $19.97 | +75.26% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $9.50 | +689.47% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $33.40 | +124.55% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.66 | +163.16% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.00 | +100.00% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.88 | +7,878.72% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $15.01 | +299.73% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $5.39 | +178.29% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.54 | +2,490.67% | 3 | Mar 16, 2022 |
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $405.02
Upside: +23.45%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $144.86
Upside: +33.92%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $7.02
Upside: +70.94%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $14.01
Upside: +92.72%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $4.79
Upside: +380.17%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $47.00
Upside: +27.66%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $23.61
Upside: +35.54%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $394.53
Upside: +39.41%
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $145.93
Upside: -17.77%
PepGen
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.48
Upside: +440.54%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $3.55
Upside: -43.66%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $25.99
Upside: +34.67%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $8.21
Upside: +70.52%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $23.46
Upside: +49.19%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $2.42
Upside: +478.51%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $20.91
Upside: +258.68%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $44.74
Upside: +51.99%
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $2.75
Upside: +263.64%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $13.14
Upside: +189.30%
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $11.65
Upside: +37.34%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $15.74
Upside: +58.83%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $14.19
Upside: +125.51%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $7.91
Upside: +279.27%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $9.87
Upside: +62.11%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $7.74
Upside: +210.08%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.43
Upside: +393.83%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $56.84
Upside: -33.15%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.60
Upside: +207.69%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $141.90
Upside: +18.39%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.09
Upside: +71.15%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.32
Upside: +733.33%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $6.97
Upside: +215.64%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.88
Upside: +128.08%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.21
Upside: +444.22%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.19
Upside: +150.48%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.02
Upside: +56.70%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $3.14
Upside: +632.48%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.76
Upside: +752.27%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $69.53
Upside: +22.25%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $19.97
Upside: +75.26%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $9.50
Upside: +689.47%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $33.40
Upside: +124.55%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.66
Upside: +163.16%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $5.00
Upside: +100.00%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $1.88
Upside: +7,878.72%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $15.01
Upside: +299.73%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $5.39
Upside: +178.29%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.54
Upside: +2,490.67%